Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 103NIH 25INDUSTRY 8NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Neoplasm Metastasis 1Gastrointestinal Stromal Tumors 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 118Radiotherapy 114Cyclophosphamide 93Paclitaxel 84Gemcitabine 74Carboplatin 67Filgrastim 60Doxorubicin 57Vincristine 56Etoposide 56Docetaxel 56Fluorouracil 51Cytarabine 41Prednisone 40Methotrexate 40Leucovorin 39Dexamethasone 37Capecitabine 36Irinotecan 35Rituximab 29Oxaliplatin 28Granulocyte Colony-Stimulating Factor 27Cetuximab 26Bevacizumab 26durvalumab 24Temozolomide 24Radiotherapy, Intensity-Modulated 24Peripheral Blood Stem Cell Transplantation 24Magnetic Resonance Spectroscopy 24Surgical Procedures, Operative 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × NETWORK × cabozantinib × Clear all
NCT01979393 2025-08-01

IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
58 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06377722 2024-04-26

Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer

Fundacion Oncosur

Phase 2 Terminated
18 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02216578 2021-07-15

Ph II CABOGIST in GIST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
51 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡